中国烧伤创疡杂志
中國燒傷創瘍雜誌
중국소상창양잡지
2012年
6期
432-438
,共7页
郑玉红%陈永翀%王志英%侯朋飞%陈洪权%王瑾%姜阿利
鄭玉紅%陳永翀%王誌英%侯朋飛%陳洪權%王瑾%薑阿利
정옥홍%진영충%왕지영%후붕비%진홍권%왕근%강아리
烧伤%感染%烧伤再生医疗技术%植皮%MEBO%SD-Ag
燒傷%感染%燒傷再生醫療技術%植皮%MEBO%SD-Ag
소상%감염%소상재생의료기술%식피%MEBO%SD-Ag
Burns%Infection%Burns Regenerative Medicine%Skin Grafting%MEBO%SD-Ag
目的对比观察烧伤再生医疗技术(MEBT/ MEBO)与烧伤外科治疗技术(SD-Ag 和/或植皮)在预防控制烧伤创面感染的临床效果.方法将60例符合入选标准的大面积重度烧伤患者随机分为研究组(MEBO组,30例)和对照组(SD-Ag 组,30例),患者入院后分别按照烧伤再生医疗技术或烧伤外科治疗技术的治疗原则,进行规范的系统治疗及创面处理.观察、记录两组患者的抗生素平均使用天数、抗生素二次使用率、侵袭性感染发生率、不同深度烧伤创面的愈合时间和手术植皮率.结果经过治疗,两组患者的创面均实现了愈合,研究组平均愈合时间34.9 d ±8.6 d,对照组平均愈合时间39.4 d ±9.1 d.抗生素平均使用天数:研究组7.5 d,对照组15.5 d.抗生素二次使用情况:研究组4例(13.3%),对照组9例(30.0%).创面侵袭性感染情况:研究组4例(13.3%),对照组20例 (66.7%).植皮手术:研究组3例(10.0%),对照组20例(66.7%).经 t 检验或χ2检验,两组间各指标相比均有显著性差异(P <0.05).结论烧伤再生医疗技术治疗大面积重度烧伤能够有效预防控制创面感染、减少抗生素使用、促进创面愈合和降低手术植皮率,收到了较好的预防控制烧伤创面感染的临床效果,值得临床推广应用和进一步深入研究.
目的對比觀察燒傷再生醫療技術(MEBT/ MEBO)與燒傷外科治療技術(SD-Ag 和/或植皮)在預防控製燒傷創麵感染的臨床效果.方法將60例符閤入選標準的大麵積重度燒傷患者隨機分為研究組(MEBO組,30例)和對照組(SD-Ag 組,30例),患者入院後分彆按照燒傷再生醫療技術或燒傷外科治療技術的治療原則,進行規範的繫統治療及創麵處理.觀察、記錄兩組患者的抗生素平均使用天數、抗生素二次使用率、侵襲性感染髮生率、不同深度燒傷創麵的愈閤時間和手術植皮率.結果經過治療,兩組患者的創麵均實現瞭愈閤,研究組平均愈閤時間34.9 d ±8.6 d,對照組平均愈閤時間39.4 d ±9.1 d.抗生素平均使用天數:研究組7.5 d,對照組15.5 d.抗生素二次使用情況:研究組4例(13.3%),對照組9例(30.0%).創麵侵襲性感染情況:研究組4例(13.3%),對照組20例 (66.7%).植皮手術:研究組3例(10.0%),對照組20例(66.7%).經 t 檢驗或χ2檢驗,兩組間各指標相比均有顯著性差異(P <0.05).結論燒傷再生醫療技術治療大麵積重度燒傷能夠有效預防控製創麵感染、減少抗生素使用、促進創麵愈閤和降低手術植皮率,收到瞭較好的預防控製燒傷創麵感染的臨床效果,值得臨床推廣應用和進一步深入研究.
목적대비관찰소상재생의료기술(MEBT/ MEBO)여소상외과치료기술(SD-Ag 화/혹식피)재예방공제소상창면감염적림상효과.방법장60례부합입선표준적대면적중도소상환자수궤분위연구조(MEBO조,30례)화대조조(SD-Ag 조,30례),환자입원후분별안조소상재생의료기술혹소상외과치료기술적치료원칙,진행규범적계통치료급창면처리.관찰、기록량조환자적항생소평균사용천수、항생소이차사용솔、침습성감염발생솔、불동심도소상창면적유합시간화수술식피솔.결과경과치료,량조환자적창면균실현료유합,연구조평균유합시간34.9 d ±8.6 d,대조조평균유합시간39.4 d ±9.1 d.항생소평균사용천수:연구조7.5 d,대조조15.5 d.항생소이차사용정황:연구조4례(13.3%),대조조9례(30.0%).창면침습성감염정황:연구조4례(13.3%),대조조20례 (66.7%).식피수술:연구조3례(10.0%),대조조20례(66.7%).경 t 검험혹χ2검험,량조간각지표상비균유현저성차이(P <0.05).결론소상재생의료기술치료대면적중도소상능구유효예방공제창면감염、감소항생소사용、촉진창면유합화강저수술식피솔,수도료교호적예방공제소상창면감염적림상효과,치득림상추엄응용화진일보심입연구.
Objective To observe and compare the clinical efficacy of Burns Regenerative Medicine ( MEBT/MEBO) and Burns Surgical Treatment (SD-Ag and/ or skin-grafting) in preventing and controlling wound infection of burns. Methods A total of 60 hospitalized patients with extensive major burns were enrolled into the study and divided into the study group (MEBO group, 30 cases) or the control group (SD-Ag group, 30 cases) randomly. After the admission, all the cases were given standard systemic treatment and wound management following the treatment principle of either Burns Re-generative Medicine or Burns Surgical Treatment. The following indexes including the average administration duration of an-tibiotics, the second-time administration rate of antibiotics, the incurrence of invasive infection, and the healing time of wounds with various depths as well as the rate of skin grafting of the two groups were observed and recorded. Results After the treatment, the wounds of the two groups all healed. The average healing time of the study group was 34. 9 ± 8. 6 d; that of the control group was 39. 4 ± 9. 1 d. As for the average administration duration of antibiotics, it was 7. 5 d for the study group and 15. 5 d for the control group. The second-time administration rate of antibiotics was 4 (13. 3% ) in the study group and 9 (30. 0% ) in the control group. Four cases (13. 3% ) in the test group developed invasive wound infection while the number for the control group was 20 (66. 7% ) . Three cases (10% ) in the study group and 20 cases in the con-trol group (66. 7% ) accepted skin grafting. Based on t test and χ2 test, all the indexes of the two groups were significantly different (P < 0. 05). Conclusion MEBT/ MEBO approach to treating extensive major burns can obtain great clinical effi-cacy in terms of effectively preventing and controlling the occurrence of wound infection, reducing the administration of anti-biotics, promoting wound healing and reducing the incurrence of skin grafting. It deserves to be promoted for wide applica-tion and further research.